Neovascular Glaucoma
📧 Sign up to get email alerts when something new happens for Neovascular Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)
A clinical trial is studying the safety of aflibercept injection in Japanese patients with neovascular glaucoma and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma [NA]
This document provides an update on a clinical trial evaluating a minimally invasive suprachoroidal drainage procedure for neovascular glauc…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Clinical Characteristics of Neovascular Glaucoma
A completed clinical trial from Zhongnan Hospital examining the clinical characteristics of neovascular glaucoma.
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT [NA]
Ongoing randomized trial comparing intracameral versus intravitreal bevacizumab for neovascular glaucoma, currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial [Phase 1]
Phase 1 trial of KDR2-2 Suspension Eyedrop for neovascular glaucoma is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-03-01Clinical Trial Update: Analysis of Aqueous and Vitreous Humor [Phase 2]
This entry reports a Phase 2 clinical trial analyzing aqueous and vitreous humor, sponsored by California Retina Consultants, for proliferat…
-
CLINICAL_TRIALS research · 2016-10-31Clinical Trial Update: Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG [Phase 2, Phase 3]
Clinical trial update on Aganirsen for ischemic central retinal vein occlusion patients at risk of neovascular glaucoma, involving Phase 2 a…
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study [Phase 3]
Phase 3 randomized trial evaluating intravitreal ranibizumab (Lucentis) for neovascular glaucoma; current status is unknown.
-
CLINICAL_TRIALS research · 2007-06-26Clinical Trial Update: Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection [NA]
Clinical trial update comparing the efficacy of silicone Ahmed glaucoma valves with and without intravitreal Triamcinolone injection in neov…